Product Overview

Mobilized peripheral blood CD34+ hematopoietic stem and progenitor cells are positively selected using a immunomagnetic CD34 microbead labeling system. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols. Manufactured by AllCells^®

Benefits

• Obtain large quantities of CD34+ from a donor

• Certificate of analysis (CoA) provided for each lot purchased

• Test negative for mycoplasma, bacteria, yeast, and fungi

• HIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lots

Applications

• CAR-T therapy development

• iPSC generation

• Autoimmune disease

• Immunology

• Cancer research

Content

1 x Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood containing ≥1/ 5/ 10/ 25 million cells

Recommended Media

Lonza X-VIVO™ 15 with L-glutamine, gentamicin, and phenol red

Lonza X-VIVO™ 15 Serum-free Hematopoietic Cell Medium, 500mL

Lonza X-VIVO™ 15 Serum-free Hematopoietic Cell Medium,1L

Lonza X-VIVO™ 15 with with L-glutamine, gentamicin, recombinant transferrin, and phenol red

Catalog #: 4Y-101C -- ≥1 million cells

Catalog #: 4Y-101D -- ≥5 million cells

Catalog #: 4Y-101E -- ≥10 million cells

Catalog #: 4Y-101F -- ≥25 million cells

Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.

Instructions and Technical Sheet- Human CD34+ Cells

Reference guidefor human and animal cells from normal to diseased, fresh and cryopreserved